期刊文献+

利培酮治疗对精神分裂症患者认知功能损害的影响 被引量:3

Effect of risperdal on schizophreniacs with cognitive function of Lesion
暂未订购
导出
摘要 目的 :探讨利培酮治疗前后 ,精神分裂症患者认知功能损害的变化。方法 :对 35例精神分裂症患者在治疗前和治疗 1 2周后均进行认知功能测验 ,包括领悟、相似性、数字广度、数字符号、填图、图片回忆、视觉再生、再认、触觉记忆和WCST中的总测验数、总错误数、持续错误数 ,且统一服用利培酮治疗。数据采用SPSS 9 0软件包进行配对T检验。结果 :利培酮治疗 1 2周后与治疗前相比 ,相似性、数字广度、数字符号、填图、图片回忆、视觉再生测验有显著性差异 (P <0 0 5)。WCST中测验总数、总错误数、持续错误数有显著性差异 (P <0 0 5)。结论 :(1 )利培酮治疗 1 2周后 ,精神分裂症患者的大部分认知功能得到改善 ,提示这部分认知功能损害具有可逆性。 (2 )利培酮治疗 1 2周后 ,仍有小部分认知功能无明显改善 ,推测此部分认知功能损害具有器质性因素 ,可能与神经学病变相关。 Objective:To explore the change of schizophrenia of cognitive lesion after risperdal.Methods:Thirty-five patients with schizophrenia of Cognitive functions were measured the detection.includ understanding,similarity,scope of digit,sign digit,picture,remembrance picture,of renew al,of vision recognition,touch memory,and WCST(total number,total error number and persistent error number).A 11 patients take Risperdal.Datas are processed with Paired-Sample T Test by SPSS 9\^0.Results:Comparison of the test of the similarity,span of digit,picture,remembrance of picture,renewal of vision were notable difference(P<0\^05)12 weekslater,WCST of total number,total error number and persistent error number were marked difference(P<0\^05)after 12 weeks.Conclusion:(1)Most of patients with schizophrenia of cognitive function were improved,Cognitive lesion reversibility after 12 weeks,(2)There are a little part of cognitive lesion had no improvement.The cognitive lesion may have tenperment foactor,and be related to the neurological lesion.
出处 《中国冶金工业医学杂志》 2003年第3期162-164,共3页 Chinese Medical Journal of Metallurgical industry
关键词 利培酮 治疗 精神分裂症 认知功能损害 领悟 相似性 Schizophrenia\ cognitive deficit\ Risperdal
  • 相关文献

参考文献9

  • 1徐贵云,郭杨波,马崔.精神分裂症认知功能损害的研究[J].中国神经精神疾病杂志,1999,25(2):128-128. 被引量:70
  • 2行养玲,杨旭,董群惠,纪术茂,韩德.首发精神分裂症患者认知功能研究[J].临床精神医学杂志,1999,9(6):334-336. 被引量:7
  • 3汤向明,侯钢,姚辉,李乐加,施为义,孔维东,谢世平,孙静,张心保.利培酮、氯丙嗪对精神分裂症患者认知功能影响的交叉试验[J].临床精神医学杂志,2000,10(3):163-165. 被引量:22
  • 4Stip E.Memory impairment in schizophrenia : perspectives form psychopathology and pharmacotherapy[J].Can J Psychiatry,1996,41(2):27-27.
  • 5Werberger DR, Gallhofer B. Cognitive function in schizophrenia. Int Clin Psyehopharmacol, 1997 ; 12:29.
  • 6Kumra S, Wiggs E, Bedwell J, et al. Neuropsychologieal deficits in pediatric patients with childhood - onset schiphrenia and psychotic disorder not otherwise specified. Schizophr - Res, 2000 ;42 (2) : 135.
  • 7Hoff AL, Riordan HO, Donnell DW, et al. Neuropsychological functioning of first - epiaade schizophreniform patients. Am J Psychiatry, 1992; 149(7) :898.
  • 8Velligan DT, Miller AL. Cognitive dysfunction in schizophrenia and its importance to outcome: the place of atypical antipsy chotics in treatment. J Clin Psychiatry, 1999 ; 23 : 25.
  • 9Kasper S, Tauscher J, Kufferle B, et al. Dopamine and aerotonin -recepters in schizophrenia: results of imaging studies and implications for pharmacotherapy in schizophrenia. Eur Arch Psychiatry Clin Neurosci, 1999; 249 (4) : 83.

二级参考文献12

  • 1侯钢,袁廷干.精神分裂症患者听觉P300的异常变化[J].中华神经精神科杂志,1993,26(2):116-118. 被引量:11
  • 2龚耀先.修订HR神经心理成套测验手册[M].长沙:湖南医科大学,1986.30-55.
  • 3龚耀先.修订韦氏记忆量表手册[M].长沙:湖南医学院,1983..
  • 4龚耀先.中国修订韦氏成人智力量表手册(第1版)[M].长沙:湖南地图出版社,1992..
  • 5行玲,国外医学.精神病学分册,1998年,25卷,3期,151页
  • 6行养玲 杨旭.精神分裂症认知功能神经心理学评定的研究进展.国外医学:精神病学分册,1998,25:151-152.
  • 71,Andersson C,Chakos M,MailmanR,et al.Emerging roles for novel antipsychotic medications in the treatment ofschizophtrnia.Psychiatr Clin North Am,1998,21:151
  • 83,Borison RL. The role of cognition in the risk-benefit and safety analysis ofantipsychotic medication.Acta Psychiatr Scand,1996,389(suppl):5
  • 94,Rossi A,Mancini F,Strata P,et al.Risperidone negative symptoms and cognitive deficitin schizophrenia:an open study.Acta Psychiatr Scand,1997,95:40
  • 105,Stip E,Lussier I.The effect of risperidone on cognition in patients withschizophrenia.Can J Psychiatry,1996,41(suppl 2):S35

共引文献94

同被引文献24

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部